{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:54Z","timestamp":1791275814989,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ajog.2014.03.054","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:14:11Z","timestamp":1395879251000},"page":"404.e1-404.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore\u2013Washington Infant Study"],"prefix":"10.1016","volume":"211","author":[{"given":"Courtney A.","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet D.","family":"Cragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Alverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.03.054_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1067\/mob.2003.223","article-title":"Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population","volume":"188","author":"Glover","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib3","series-title":"Drugs for pregnant and lactating women","author":"Weiner","year":"2009"},{"key":"10.1016\/j.ajog.2014.03.054_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.physiol.63.1.451","article-title":"Genetic assembly of the heart: implications for congenital heart disease","volume":"63","author":"Srivastava","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajog.2014.03.054_bib5","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/CIRCULATIONAHA.106.183216","article-title":"Noninherited risk factors and congenital cardiovascular defects: current knowledge; a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; endorsed by the American Academy of Pediatrics","volume":"115","author":"Jenkins","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2014.03.054_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.109.129098","article-title":"Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations","volume":"54","author":"Caton","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2014.03.054_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/bdrb.10005","article-title":"Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits","volume":"68","author":"Cook","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bdrb.10003","article-title":"NSAIDs and developmental toxicity","volume":"68","author":"Tassinari","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0100-879X2006000700011","article-title":"Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors","volume":"39","author":"Burdan","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ajog.2014.03.054_bib10","volume":"vol. 5","author":"Ferencz","year":"1997"},{"key":"10.1016\/j.ajog.2014.03.054_bib11","volume":"vol. 4","author":"Ferencz","year":"1993"},{"key":"10.1016\/j.ajog.2014.03.054_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0146-0005(96)80062-0","article-title":"Pathogenetic mechanisms of congenital cardiovascular malformations revisited","volume":"20","author":"Clark","year":"1996","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2014.03.054_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0895-4356(93)90132-K","article-title":"Use of prescription and non-prescription drugs in pregnancy: the Baltimore\u2013Washington Infant Study Group","volume":"46","author":"Rubin","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2014.03.054_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0735-1097(89)90122-8","article-title":"Congenital cardiovascular malformations: questions on inheritance; Baltimore\u2013Washington Infant Study Group","volume":"14","author":"Ferencz","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2014.03.054_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/bdrb.10008","article-title":"Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure","volume":"68","author":"Cappon","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bdrb.10007","article-title":"Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms","volume":"68","author":"Gupta","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2014.03.054_bib18","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM198912143212404","article-title":"The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects","volume":"321","author":"Werler","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.03.054_bib19","doi-asserted-by":"crossref","first-page":"e22174","DOI":"10.1371\/journal.pone.0022174","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study","volume":"6","author":"van Gelder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2014.03.054_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","article-title":"Nonsteroidal anti-inflammatory drugs in early pregnancy","volume":"15","author":"Ericson","year":"2001","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.ajog.2014.03.054_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ajog.2007.08.040","article-title":"Acetaminophen use during pregnancy: effects on risk for congenital abnormalities","volume":"198","author":"Rebordosa","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0b013e3181c52616","article-title":"Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study","volume":"115","author":"Feldkamp","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bdra.20005","article-title":"Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects","volume":"70","author":"Cleves","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2014.03.054_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib26","doi-asserted-by":"crossref","first-page":"222.e1","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"Nonsteroidal anti-inflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.03.054_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2014.03.054_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-9926(200005)61:5<368::AID-TERA8>3.0.CO;2-N","article-title":"Interrupted aortic arch: an epidemiologic study","volume":"61","author":"Loffredo","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2014.03.054_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.aje.a114286","article-title":"Effect of questionnaire design on recall of drug exposure in pregnancy","volume":"123","author":"Mitchell","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2014.03.054_bib30","unstructured":"Micromedex Healthcare Series. Version 5.1. Greenwood Village, CO: Thomson Healthcare. Available at: www.micromedex.com. Accessed Jan. 28,\u00a02013."}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814002828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814002828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:59:51Z","timestamp":1757588391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0002937814002828"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.03.054","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore\u2013Washington Infant Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}